Publisher
Springer Science and Business Media LLC
Reference114 articles.
1. World Health Organization. Combating hepatitis B and C to reach elimination by 2030: Advocacy Brief May 2016. Available at: http://www.who.int. Accessed February 7, 2021.
2. Polaris Observatory of HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol. 2017;2(3):161-76.
3. Martinez MA, Franco S. Therapy implications of hepatitis C virus genetic diversity. Viruses. 2020;13(1).
4. Sorbo MC, Cento V, Di Maio VC, Howe AYM, Garcia F, Perno CF, et al. Hepatitis C virus drug resistance associated substitutions and their clinical relevance: Update 2018. Drug Resist Updat. 2018;37:17-39.
5. Bourgi K, Brar I, Baker-Genaw K. Health disparities in hepatitis C screening and linkage to care at an integrated health system in Southeast Michigan. PLoS One. 2016;11(8):e0161241.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献